Valeria Caggiano

Siena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.

Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.

Journal: Clinical and experimental rheumatology

Published: May 07, 2026

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group.

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group.

Journal: Frontiers in immunology

Published: April 10, 2026

Dry eye disease in axial spondyloarthritis: heterogeneous ocular surface dysfunction involving tear film instability and tear production from the AIDA network registry.

Dry eye disease in axial spondyloarthritis: heterogeneous ocular surface dysfunction involving tear film instability and tear production from the AIDA network registry.

Journal: Frontiers in medicine

Published: April 09, 2026

Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.

Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.

Journal: Frontiers in pharmacology

Published: April 03, 2026

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Journal: Seminars in arthritis and rheumatism

Published: February 24, 2026

Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis Registry.

Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis Registry.

Journal: Ophthalmology and therapy

Published: February 17, 2026

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry.

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry.

Journal: Frontiers in immunology

Published: February 14, 2026

Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network.

Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network.

Journal: Rheumatology (Oxford, England)

Published: February 10, 2026

Irreversible Ocular and Systemic Damage in ROSAH Syndrome.

Irreversible Ocular and Systemic Damage in ROSAH Syndrome.

Journal: Ophthalmology and therapy

Published: January 07, 2026

Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profile.

Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profile.

Journal: Internal and emergency medicine

Published: January 02, 2026

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry.

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry.

Journal: Frontiers in immunology

Published: December 30, 2025

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Journal: Frontiers in immunology

Published: November 24, 2025

Showing 1-12 of 74

Last Updated: 09/26/2026